Scholarly Index

John J.P. Kastelein

QRx Pharma (United States); 134,720 total citations; 1,069 total publications; best world rank #3

QRx Pharma (United States)

134,720Total citations
1,069Total publications
166H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Medical and Health SciencesLifetime468US 25699.98
SurgeryLifetime13US 599.99
Endocrinology, Diabetes and MetabolismLifetime203US 11099.40
Cardiology and Cardiovascular MedicineLifetime631US 33198.94
Cancer ResearchLifetime372US 20297.80
Surgery2021-202543US 1799.75
Endocrinology, Diabetes and Metabolism2021-2025367US 14590.69
Cancer, Lipids, and MetabolismLifetime4US 399.95
Lipoproteins and Cardiovascular HealthLifetime5US 299.96
Lipid metabolism and disordersLifetime4US 299.83
Pharmaceutical Economics and PolicyLifetime3US 399.72
Diabetes, Cardiovascular Risks, and LipoproteinsLifetime12US 799.94
Health Systems, Economic Evaluations, Quality of LifeLifetime75US 3699.68
Atherosclerosis and Cardiovascular DiseasesLifetime35US 2199.55
Cholesterol and Lipid MetabolismLifetime35US 2299.36
Cardiovascular Health and Disease PreventionLifetime257US 11698.65
Adipokines, Inflammation, and Metabolic DiseasesLifetime326US 14398.49
Antiplatelet Therapy and Cardiovascular DiseasesLifetime315US 12898.47
Peroxisome Proliferator-Activated ReceptorsLifetime889US 38095.09
Paraoxonase enzyme and polymorphismsLifetime140US 3491.28
Cynara cardunculus studiesLifetime330US 3776.13
Lipoproteins and Cardiovascular Health2021-202528US 1499.39
Diabetes, Cardiovascular Risks, and Lipoproteins2021-202532US 1498.83
Pharmaceutical Economics and Policy2021-202516US 798.31
Health Systems, Economic Evaluations, Quality of Life2021-2025306US 9996.97
Cancer, Lipids, and Metabolism2021-2025166US 4494.89
Antiplatelet Therapy and Cardiovascular Diseases2021-2025481US 9190.18
Lipid metabolism and disorders2021-2025154US 4285.85
Cholesterol and Lipid Metabolism2021-2025209US 4977.90